Cargando…

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy

Detalles Bibliográficos
Autores principales:	Costa, JLF, Ferreira, J, Teles, C, Gutierrez, F, Mesquita, A, Costa-Filho, RC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301183/ http://dx.doi.org/10.1186/cc5843

Ejemplares similares

Impact of renal scintigraphy in severe patients with acute renal failure
por: Ferreira, JF, et al.
Publicado: (2005)

Application of a new Candida score for early antifungal treatment in an adult medical – surgical critical care unit
por: Santos, M, et al.
Publicado: (2007)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

Comparison of antimicrobial resistance rates in an ICU in Rio de Janeiro, Brazil and the United States
por: Santos, MS, et al.
Publicado: (2005)

Results of an intensive insulin infusion protocol in diabetic and nondiabetic critically ill patients
por: Gomes, PN, et al.
Publicado: (2005)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Bilevel plus PSV and nitric oxide as an alternative ventilatory strategy in acute respiratory distress syndrome patients
por: Saddy, F, et al.
Publicado: (2007)

The use of renal scintigraphy with technetium-99m-L,L-ethylenedicysteine in critically ill patients with acute renal failure in the intensive care unit
por: Corrêa, PL, et al.
Publicado: (2003)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Rotational thromboelastography in a patient with heparin-induced thrombocytopenia: a case report
por: Silva, EA, et al.
Publicado: (2007)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Validation of a semi-quantitative bedside procalcitonin measurement in intensive care patients
por: Vaisman, M, et al.
Publicado: (2005)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Effective dosage of enoxaparin for intensive care patients
por: Robinson, S, et al.
Publicado: (2013)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Supratherapeutic anti-factor Xa levels in patients receiving prophylactic doses of enoxaparin: A case series
por: Pannucci, Christopher J., et al.
Publicado: (2016)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

An audit of antibiotic dosing according to renal function or renal replacement therapy in critical care
por: Donnelly, KD, et al.
Publicado: (2011)

Anti-activated factor × response to enoxaparin in critically ill patients
por: Einav, S, et al.
Publicado: (2009)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Utilization of a tool to help intensivists in the implementation and monitoring of the ventilator-associated pneumonia bundle protocol running in an adult medical – surgical critical care unit
por: Santos, M, et al.
Publicado: (2007)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c5uh2ua4usc9p5f28t9itj14r9